Regulation of tissue resident macrophage development by IL-7R signaling
IL-7R 信号传导调节组织驻留巨噬细胞发育
基本信息
- 批准号:9883828
- 负责人:
- 金额:$ 37.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-01 至 2020-03-15
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAddressAdoptive TransferAdultAutomobile DrivingBloodCell physiologyCellsCharacteristicsCuesCytokine ReceptorsDataDevelopmentDevelopmental ProcessDiseaseEpidermisFetal DevelopmentFetal LiverFetal TissuesGenetic TranscriptionGoalsHematopoiesisHematopoieticHematopoietic stem cellsHomeostasisIL7 geneIL7R geneImmuneImmunityImmunologic SurveillanceImpairmentInterleukin 7 ReceptorInterleukin-7InvestigationKnowledgeLabelLongevityLungLymphocyteLymphoidMaintenanceMolecularMusMyelogenousMyeloid CellsNatural regenerationNatureNormal tissue morphologyPathogenesisPathway interactionsPregnancyProcessProductionPropertyReceptor SignalingRecording of previous eventsRegulationResearch Project GrantsRoleShapesSignal PathwaySignal TransductionSpecific qualifier valueSurfaceTimeTissuesTransducersWorkbrain tissueexperimental studyfetalgenetic approachimmune functioninsightmacrophagemonocytenovelprogenitorprotein expressionreceptorself-renewal
项目摘要
The recent discovery that adult hematopoietic (blood) stem cells (HSCs) do not produce all immune cells
despite sustaining blood production across the lifespan has fundamentally challenged our understanding of
both immune development and function. Adoptive transfer studies and fate mapping experiments have
demonstrated that tissue-resident macrophages are only specified during fetal development and cannot be
generated or regenerated in adulthood. As compared to their adult HSC-derived counterparts, fetal-derived
tissue resident macrophages reside and self-renew within their resident tissues, where they perform distinct
homeostatic and immune surveillance functions. The discovery of a fetal origin of tissue-resident macrophages
has raised many new questions about their specification, persistence across the lifespan, and distinct function.
The long-term objective of this proposal is to define the developmental mechanisms underlying the unique
functional capacity of tissue resident macrophages across the lifespan in order to illuminate their distinct role in
both adult tissue homeostasis and disease. Recent work in our lab has identified interleukin-7 receptor (IL-7R)
signaling as a novel mechanism regulating the establishment of tissue resident macrophages during fetal
development. IL-7R signaling is restricted to regulation of the lymphoid lineage in adult hematopoiesis. The
reliance of fetal myeloid specification on IL-7R signaling suggests that fetal hematopoiesis exploits alternate
differentiation pathways in order to confer distinct characteristics on fetal-derived macrophages. In this
proposal, we will capitalize on the discovery of this new regulatory mechanism to dig deeper into how these
distinct immune cells are specified from fetal precursors during development. In Aim 1, we will use genetic
approaches to determine the requirement for IL7R signaling during fetal myeloid specification. We will
specifically delete the receptor sub-chain IL7raain a range of progenitors and mature cells at different stages of
development to define how IL7rα regulates myeloid specification during fetal development. In Aim 2, we will
define for the first time how IL-7R signaling occurs in myeloid cells - including downstream signal transducers
and transcriptional targets- and the specific developmental processes that are regulated by IL-7R signaling
during fetal macrophage establishment. In Aim 3, we will establish the function of IL-7 as a fetal myeloid niche
factor and define both the requirement for IL-7 and which cell subsets are responsible for producing IL-7 within
resident tissues to support macrophage development. Together, work from the proposed studies will illuminate
how alternative differentiation pathways during fetal hematopoiesis impart distinct functional characteristics on
fetal-derived tissue resident macrophages, and thereby illuminate the role of specific ontogenetic subsets of
macrophages in normal tissue and disease processes.
最近发现成人造血干细胞(HSCs)并不能产生所有的免疫细胞
尽管在整个生命周期内维持血液生产从根本上挑战了我们对
包括免疫发育和免疫功能。采用迁移研究和命运映射实验
证明组织驻留的巨噬细胞只在胎儿发育过程中被指定,不能
成年的成年后产生或再生的与成年HSC来源的同龄人相比,胎儿来源的
组织驻留巨噬细胞驻留并在其驻留组织内自我更新,在那里它们执行不同的
动态平衡和免疫监视功能。组织驻留巨噬细胞起源于胎儿的发现
对它们的规范、在整个生命周期中的持久性和独特的功能提出了许多新的问题。
这项提议的长期目标是定义独特的
组织驻留巨噬细胞在整个寿命中的功能能力,以阐明它们在
成人组织的动态平衡和疾病。我们实验室最近的工作发现了白细胞介素7受体(IL-7R)
信号作为一种新的机制调节胎儿组织驻留巨噬细胞的建立
发展。IL-7R信号仅限于成人造血中淋巴系的调节。这个
胎儿髓系对IL-7R信号的依赖提示胎儿造血利用替代
分化途径,以赋予胎儿来源的巨噬细胞不同的特征。在这
提议,我们将利用这一新的监管机制的发现,更深入地挖掘这些
在发育过程中,不同的免疫细胞是从胎儿前体细胞中特定出来的。在目标1中,我们将使用基因
在胎儿髓系规范过程中确定IL7R信号需求的方法。我们会
具体地,删除受体亚链IL7来自一系列处于不同阶段的祖细胞和成熟细胞
研究进展以确定IL7rα如何在胎儿发育过程中调节髓系规格。在目标2中,我们将
首次确定IL-7R信号如何在髓系细胞中发生--包括下游信号转导
和转录靶点--以及受IL-7R信号调控的特定发育过程
在胎儿巨噬细胞建立过程中。在目标3中,我们将建立IL-7作为胎儿髓系利基的功能
因子和定义对IL-7的需求以及哪些细胞亚群负责在
支持巨噬细胞发育的常驻组织。总之,来自拟议研究的工作将阐明
胎儿造血过程中不同的分化途径如何赋予细胞不同的功能特征
胎儿来源的组织驻留巨噬细胞,从而阐明特定的个体发育亚群在
正常组织和疾病过程中的巨噬细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anna E. Beaudin其他文献
A "Switch" in Time through Genes Aligned: Unraveling the Genomic Landscape of HSC Development.
通过基因对齐实现时间上的“转换”:揭示 HSC 发育的基因组景观。
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:23.9
- 作者:
April C. Apostol;Diego A. López;Anna E. Beaudin - 通讯作者:
Anna E. Beaudin
The impact of prenatal inflammation on hematopoietic development
产前炎症对造血发育的影响
- DOI:
10.1097/moh.0000000000000770 - 发表时间:
2023 - 期刊:
- 影响因子:3.2
- 作者:
Nicole A. Tseng;Anna E. Beaudin - 通讯作者:
Anna E. Beaudin
Maternal Mthfd 1 disruption impairs fetal growth but does not cause neural tube defects in mice 1 – 3
母体 Mthfd 1 破坏会损害胎儿生长,但不会导致小鼠神经管缺陷 1 – 3
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
Anna E. Beaudin;Cheryll A. Perry;S. Stabler;R. Allen;P. Stover - 通讯作者:
P. Stover
IL7Rα is required for hematopoietic stem cell reconstitution of tissue-resident lymphoid cells
IL7Rα 是组织驻留淋巴细胞的造血干细胞重建所必需的
- DOI:
10.1101/2021.07.13.452134 - 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Atesh K. Worthington;T. Cool;Donna M. Poscablo;Adeel Hussaini;Anna E. Beaudin;E. Forsberg - 通讯作者:
E. Forsberg
IL7r-alpha fate-mapping labels distinct adult tissue resident macrophages
- DOI:
10.1016/j.exphem.2017.06.318 - 发表时间:
2017-09-01 - 期刊:
- 影响因子:
- 作者:
Anna E. Beaudin;Taylor McCann;Gabriel Leung;E. Camilla Forsberg - 通讯作者:
E. Camilla Forsberg
Anna E. Beaudin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anna E. Beaudin', 18)}}的其他基金
Regulation of hematopoietic stem cell function by prenatal folate status
产前叶酸状态对造血干细胞功能的调节
- 批准号:
10373851 - 财政年份:2022
- 资助金额:
$ 37.32万 - 项目类别:
Regulation of hematopoietic stem cell function by prenatal folate status
产前叶酸状态对造血干细胞功能的调节
- 批准号:
10544803 - 财政年份:2022
- 资助金额:
$ 37.32万 - 项目类别:
Regulation of tissue resident macrophage development by IL-7R signaling
IL-7R 信号传导调节组织驻留巨噬细胞发育
- 批准号:
10303707 - 财政年份:2019
- 资助金额:
$ 37.32万 - 项目类别:
Regulation of tissue resident macrophage development by IL-7R signaling
IL-7R 信号传导调节组织驻留巨噬细胞发育
- 批准号:
10330485 - 财政年份:2019
- 资助金额:
$ 37.32万 - 项目类别:
Regulation of tissue resident macrophage development by IL-7R signaling
IL-7R 信号传导调节组织驻留巨噬细胞发育
- 批准号:
10574553 - 财政年份:2019
- 资助金额:
$ 37.32万 - 项目类别:
Contribution of a novel, developmentally-restricted hematopoietic stem cell
一种新型的、发育受限的造血干细胞的贡献
- 批准号:
9165344 - 财政年份:2016
- 资助金额:
$ 37.32万 - 项目类别:
Contributio of a novel developmentally-restricted hematopoietic stem cell
新型发育受限造血干细胞的贡献
- 批准号:
9753330 - 财政年份:2016
- 资助金额:
$ 37.32万 - 项目类别:
Contributio of a novel developmentally-restricted hematopoietic stem cell
新型发育受限造血干细胞的贡献
- 批准号:
9316702 - 财政年份:2016
- 资助金额:
$ 37.32万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.32万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.32万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.32万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.32万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.32万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.32万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.32万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.32万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.32万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.32万 - 项目类别:
Research Grant














{{item.name}}会员




